We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Hypertrophic Scarring After Treatment With Fluorouracil, 2%, in Pyruvic Acid, 98%, for Verruca Vulgaris

Matthew R. Donaldson, MD; Cloyce L. Stetson, MD
Arch Dermatol. 2010;146(2):213-214. doi:10.1001/archdermatol.2009.338.
Text Size: A A A
Published online


Halasz  CLG Treatment of warts with topical pyruvic acid: with and without added 5-fluorouracil. Cutis 1998;62 (6) 283- 285
Tosson  ZAttwa  EAl-Mokadem  S Pyruvic acid as a new therapeutic peeling agent in acne, melasma, and warts. EDOJ 2006;2 (2) 7
Gibbs  SHarvey  I Topical treatments for cutaneous warts. Cochrane Database Syst Rev 2006;19 (3) CD001781
Kaplan  LAWalter  JFMacknet  KD Hypertrophic scarring as a complication of Fluorouracil therapy. Arch Dermatol 1979;115 (12) 1452
PubMed Link to Article[[XSLOpenURL/10.1001/archderm.1979.04010120048021]]
Fitzpatrick  RE Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999;25 (3) 224- 232
Griffin  TDVan Scott  EJMaddin  S The use of pyruvic acid as a chemical peeling agent. J Dermatol Surg Oncol 1989;151316
Griffin  TDVan Scott  EJ Use of pyruvic acid in the treatment of actinic keratoses: a clinical and histopathologic study. Cutis 1991;47 (5) 325- 329
Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption

Patient arm demonstrating firm, pink, hypertrophic scars.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

1 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections